Product
UPB-101
Aliases
Formerly ASP7266
2 clinical trials
2 indications
Indication
HealthyIndication
AsthmaClinical trial
A Randomized, Open-label, Parallel-group, Ethno-bridging Study Comparing the Pharmacokinetics and Safety of a Single Dose of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian AdultsStatus: Completed, Estimated PCD: 2023-04-07
Clinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple Ascending-Dose Study to Assess the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of UPB-101 in Subjects With AsthmaStatus: Completed, Estimated PCD: 2023-08-15